For Klick, IPG Health, McCann Health, CDM & Calcium Insights Teams

Run continuous concept and KOL research within one subscription

AI-moderated voice and video research with verified HCP audiences. Clears pharma client procurement in under 14 days. BAA + Sunshine Act + stimuli pre-approval handling on every engagement. Monthly subscription with 50 interviews included — always-on listening for healthcare ad agency creative cycles without sacrificing rigor.

Monthly subscription with 50 interviews included; always-on listening capability
BAA + Sunshine Act + stimuli pre-approval on every engagement
Clears pharma client procurement in under 14 days
Verified clinician on a Carevoices research interview
Live

Trusted by teams at

Nivella Health
TL;DR

Healthcare ad agencies (Klick, IPG Health, McCann Health, CDM) face three mismatches generic research vendors don't solve: pharma vendors run 8-12 week procurement while agency creative runs 4-6 weeks; concept tests trigger BAA + Sunshine Act + stimuli pre-approval depth generic AI tools lack; and pharma client retention demands iteration legacy KOL programs miss. Carevoices delivers AI-moderated voice/video interviews with verified HCPs — recruited in 7-21 days, HIPAA Safe Harbor de-identified, BAA, Sunshine Act-ready, stimuli pre-approval, co-branded / white-label deliverables. Monthly subscription replaces RFP cycles; clears pharma client procurement in under 14 days.

The Problem

Why Healthcare Agencies Hate Pharma Research Vendors

Three structural mismatches that generic research vendors and incumbent KOL programs don't solve.

01

Pharma research vendors operate at procurement pace, not agency pace

M3, Sermo, ZoomRx engagements take 8-12 weeks from RFP to deliverable. Agency creative cycles run 4-6 weeks. The math doesn't work — research arrives after the client briefs the next campaign. Without same-week fielding, agencies ship creative without HCP signal, or run on instinct alone.

02

Every concept test triggers compliance gates generic AI tools fail

FDA-relevant content requires stimuli pre-approval workflow with versioning and audit trail. Pharma client procurement gates every vendor on BAA, HIPAA, US data residency, and Sunshine Act handling. Generic AI research tools (Listen Labs, Outset, Strella) don't publish BAAs as of April 2026, don't have stimuli pre-approval workflows, and fail every check. Legacy vendors bolt compliance documentation onto every engagement as a separate workstream that delays fielding 30-60 days.

03

Pharma client retention demands creative iteration cadence vendors can't match

Pharma client research demands are rising — more concept testing, more message validation, more KOL inputs per pitch and per campaign. Incumbent vendors at 8-12 week cycle times cap how many iterations agencies can run. Without 2-3 iteration rounds per creative engagement, agencies lose pharma client retentions to competitors who can run faster.

04

RFP responses and new-business pitches ship without HCP signal

Agency new-business teams have 2-3 weeks from pharma RFP receipt to final pitch — never enough to commission custom HCP research from incumbent vendors at 8-12 week cycles. Pitches go in with category framing pulled from secondary sources or stale prior-engagement data. The agencies that win RFPs increasingly bring fresh, defensible HCP voice to the pitch deck — and the gap is structural.

The Solution

How Does Carevoices Compress Healthcare Agency Research?

Healthcare agencies use Carevoices to run AI-moderated voice and video interviews with verified HCP audiences, recruited in 7-21 days, delivered as HIPAA Safe Harbor de-identified transcripts under BAA with Sunshine Act-ready data handling and stimuli pre-approval workflow built in. A monthly subscription with 50 interviews included replaces bespoke per-project RFP cycles — concept testing, message validation, KOL research, and rapid creative testing all run within the same engagement. Co-branded and white-label deliverables accommodate pharma sponsor client work. The compliance posture clears pharma client procurement in under 14 days because the questions they ask are pre-answered in our standard documentation.

How does Carevoices clear pharma client procurement faster than other vendors?

BAA template ready pre-signature; HIPAA Safe Harbor de-identification methodology documented in writing; US data residency confirmed in contract; Sunshine Act / Open Payments-ready data handling captured at panelist intake; stimuli pre-approval workflow with versioning and audit trail built in. Most pharma client compliance reviews clear Carevoices in under 14 days because the questions they ask are pre-answered in our standard documentation.

Can we white-label or co-brand deliverables for our pharma sponsor clients?

Yes. Co-branded and white-label deliverables are accommodated for healthcare agency partnerships. Standard contract structure supports presenting deliverables under your agency brand or co-branded with the pharma sponsor. Discuss specific branding and deliverable format on demo call.

What does Carevoices' monthly subscription unlock vs. incumbent KOL programs and panel rentals?

AI-native delivery, a monthly subscription with 50 interviews included replacing bespoke per-project RFP cycles, compliance-as-architecture rather than retrofit, and always-on listening capability across the campaign. Fielding starts the same week the brief is locked. The structural difference unlocks 2-3 concept iteration rounds in a single agency creative engagement vs. one-shot validation at incumbent vendors — material competitive advantage when defending pharma client retentions.

Use Cases

How For Klick, IPG Health, McCann Health, CDM & Calcium Insights Teams use
Carevoices

Compliance Built In

BAA on every engagement, template available pre-signature. HIPAA Safe Harbor de-identification by default. US data residency confirmed in writing. Sunshine Act / Open Payments-ready data handling — NPI capture + CMS-format export. Stimuli pre-approval workflow with versioning and audit trail for FDA-relevant content. Co-branded and white-label deliverables for pharma sponsor client work.

Pharma client compliance reviews clear the engagement in under 14 days

Faster Insights

Fielding starts the same week the brief is locked. AI-moderated voice and video interviews with verified HCP audiences from a 10k+ healthcare panel. Recruitment takes 7-14 days for mainstream specialties; 14-28 days for rare subspecialties. Same-week fielding fits agency creative review cycles.

Sprint-cadence HCP signal vs. 8-12 weeks per project at incumbent vendors

Always-On Listening

Monthly subscription with 50 interviews included means the next concept test fields the moment the prior one closes. Run multiple concept iterations within one subscription cycle — concept testing, message validation, KOL research, and creative testing all within the same engagement, no per-project procurement cycle between studies.

2-3 concept iteration rounds per creative engagement vs. one-shot validation

RFP Response & Pitch-Development Research

Same-week fielding fits agency new-business cycles. Run rapid HCP audience interviews to inform RFP responses, pitch decks, and competitive-displacement narratives — verified specialty physicians and nurses, BAA + Sunshine Act handling included, co-branded deliverables for the pitch. Fresh, defensible HCP voice on the deck instead of secondary-source category framing.

Agencies bring current HCP signal to RFPs; new-business win rates lift on defensible insights
Compare

How Carevoices compares to common healthcare agency research alternatives

Dimension Carevoices M3 / Sermo panel rentalsTraditional agency-side research vendors (ZoomRx-style)Listen Labs / Outset / generic AI tools
Engagement model Monthly subscription with 50 interviews included; same-week fielding Annual panel-access subscription + per-survey feesRFP-driven custom engagement, 30-90 day procurementCustom RFP-driven engagement design
AI-moderated voice/video qualitative Native — primary delivery mechanism Survey + community methodologyHybrid AI + human moderationYes — but no healthcare compliance package
BAA + Sunshine Act + stimuli pre-approval Yes — all three pre-built; clears pharma client procurement in under 14 days BAA standard; stimuli pre-approval not nativeYes — bolt-on per engagement, 30-60 day legal cycleNo published BAA; no native stimuli pre-approval workflow
Co-branded / white-label deliverables Yes — accommodated for healthcare agency partnerships Limited — typically vendor-branded deliverablesSometimes — depends on vendorLimited — typically vendor-branded deliverables
Iteration speed inside an agency creative cycle 2-3 concept iteration rounds within one subscription cycle Per-survey fees on every roundNew RFP cycle per roundCustom-scoped per round; no compliance reuse
How It Works

How healthcare agencies use Carevoices

1
Day 1

Brief us

You define the study question and audience. Our research agent translates the brief into a structured learning plan within 24 hours; recruitment feasibility confirmed before contract.

2
Days 2–14

We recruit and moderate

AI-moderated voice or video interviews with verified clinicians. License + NPI verified at intake, behavioral fingerprinting across interviews, AI-on-AI fraud detection on every conversation.

3
Days 15–17

We de-identify and deliver

Transcripts and recordings stripped of all 18 HIPAA Safe Harbor identifiers, then delivered to your team in standard formats your existing analysis stack already accepts.

4
Days 18–21

You analyze

You analyze the de-identified data using your existing tools and team. We don't replace your analysis stack — we feed it the qualitative data your current vendors can't recruit for fast enough.

"We were CROs competing on speed alone, but patient research was the bottleneck — we would quote 8-week timelines while sponsors went to bigger firms in the US and Europe. Carevoices changed the math. We ran 1,203 patient interviews in 48 hours for one sponsor, with HIPAA-grade de-identified transcripts delivered straight into our analysis stack, and the AI moderator went deeper than our human moderators on the first round. Sponsors come to us specifically now because we can do depth research at scale — 34% recruitment uplift, 52% retention. We can now compete globally because of Carevoices."

Stephane Nyombaire, CEO, Nivella Health

Methodology & Trust

The Carevoices Difference for Healthcare Agency Research

Generic AI research tools and consumer-grade research platforms can be retrofit for healthcare agency engagements — but the retrofit shows, and pharma client procurement catches it. Carevoices is built around healthcare compliance and pharma-client-pass-through documentation from day one. Here's how the architecture compares.

Carevoices Healthcare-Vertical Architecture

  • BAA on every engagement, template available pre-signature
  • License + NPI verified HCP panel (NPPES Registry cross-check at intake)
  • HIPAA Safe Harbor de-identification built into delivery pipeline
  • Sunshine Act / Open Payments-ready data handling — NPI capture + CMS-format export
  • Stimuli pre-approval workflow with versioning and audit trail for FDA-relevant content
  • Co-branded and white-label deliverables for pharma sponsor client work
  • Pharma client procurement clears Carevoices in under 14 days
  • 0.4% verified AI-respondent leak rate via 6-Layer Fraud Detection Stack
  • PHI never trains a model — period

What Generic AI Research Tools Require

  • BAA execution often unavailable or 60-120+ day legal retrofit
  • Self-identified panel without license verification or NPI cross-check
  • De-identification typically a post-fielding service charge or skipped entirely
  • Sunshine Act handling not built; bolt-on per engagement
  • No native stimuli pre-approval workflow for FDA-relevant content
  • Vendor-branded deliverables; no co-brand or white-label flexibility
  • Pharma client procurement disqualifies most generic AI vendors at the BAA gate
  • Legacy fraud detection that PNAS 2025 shows AI bots evade 99.8% of the time
  • PHI in model training pipeline unless explicitly contracted otherwise

In progress: SOC 2 Type II audit (in evidence-collection phase). HITRUST CSF and ISO 27001 are 2026-2027 roadmap. Letter of audit attestation available on request to qualified prospects under NDA.

Get Started

Run your next concept test the week the brief is locked

Walk through your current pharma client research backlog. See how the monthly subscription fits agency creative cycles. Get a sample compliant deliverable from a recent agency engagement.

30-min with founder

Walkthrough of a sample compliant deliverable and how the monthly subscription fits your agency creative cycles

For your strategy team

Sample HIPAA-grade de-identified transcript and analysis from a recent concept testing or KOL engagement, with co-brand options

For pharma client procurement

BAA template, HIPAA Safe Harbor methodology, US data residency commitment, Sunshine Act handling, stimuli pre-approval workflow

Most pharma client procurement reviews clear Carevoices in under 14 days.

FAQ

Common questions

Yes. BAA is standard on every healthcare engagement, included in every contract. Custom terms accommodated when your pharma client's legal team needs them. Template available on request before signature. Most BAAs execute within 5-10 business days.
Most pharma client compliance reviews clear Carevoices in under 14 days. Standard BAA template, HIPAA Safe Harbor methodology documentation, US data residency commitment language, Sunshine Act handling documentation, and stimuli pre-approval workflow are all pre-built. Custom client procurement requirements accommodated as needed.
Yes. Co-branded and white-label deliverables are accommodated for healthcare agency partnerships. Standard contract structure supports presenting deliverables under your agency brand or co-branded with the pharma sponsor. Multi-engagement contract structure with priority recruitment slots and dedicated success management available for agencies running 5+ engagements per year.
Yes. Stimuli upload, versioning, lock workflow, audit trail per stimulus per panelist — all built in. Designed for pharma client medical regulatory review.
Default-blinded studies — your team and your sponsor's team never learn participant identity, so transfers of value typically don't trigger reporting. For unblinded engagements (advisory boards), we provide CMS-format export data for your sponsor's filing. Our panelist intake captures NPI, state license, specialty, and address — export-ready by design.
The monthly subscription with 50 interviews included replaces per-project RFP cycles with always-on listening: fielding starts the same week the brief is locked, BAA + compliance bundled. Concept testing, message validation, KOL research, and creative testing all run within the subscription. 2-3 concept iteration rounds in a single agency creative engagement vs. one-shot validation at incumbents — competitive advantage when defending pharma client retentions.
M3 and Sermo are panel-access subscriptions — annual fees plus per-survey fees, with you assembling moderation and de-identification. Carevoices is a delivered-study subscription bundling recruitment, AI voice/video, transcription, HIPAA Safe Harbor, BAA, Sunshine Act, and stimuli pre-approval. M3 and Sermo are stronger for international tracker breadth; Carevoices is built for AI-moderated work where same-week fielding and stimuli pre-approval matter more.
Generic AI research tools were built for consumer brands and haven't retrofit healthcare compliance. Most don't publish a BAA template, don't run license + NPI verification, don't de-identify to HIPAA Safe Harbor by default, lack stimuli pre-approval for FDA content, and don't accommodate co-brand/white-label deliverables for pharma sponsors. Pharma client compliance typically disqualifies them at the BAA gate, or accepts a 60-120+ day retrofit.
Explore More

Go deeper on For Klick, IPG Health, McCann Health, CDM & Calcium Insights Teams